ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,687Medicare Part D Prescriptions Filled, Including Refills

Rank: 155 out of 3593

$1.3M Total Retail Price of All Prescriptions

Rank: 74 out of 3593

735 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 735 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

3% of this provider’s 16,768 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

39% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
OMEPRAZOLE 694 644 1 5
LISINOPRIL 458 436 2 2
CRESTOR 416 371 3 21
LEVOTHYROXINE SODIUM 416 365 3 4
NEXIUM 414 337 5 36
METFORMIN HCL 398 372 6 6
SIMVASTATIN 376 347 7 1
IBUPROFEN 350 301 8 43
PLAVIX 347 305 9 42
NAMENDA 326 292 10 50
ZOLPIDEM TARTRATE 324 292 11 12
METOPROLOL TARTRATE 304 288 12 8
RANITIDINE HCL 297 294 13 27
VIAGRA 276 245 14 84
GABAPENTIN 271 258 15 16
VOLTAREN 266 247 16 85
LANSOPRAZOLE 259 244 17 113
AMLODIPINE BESYLATE 253 244 18 3
ADVAIR DISKUS 249 153 19 47
DIOVAN HCT 244 210 20 76
CLOPIDOGREL 240 224 21 30
ATENOLOL 238 237 22 11
DIOVAN 231 202 23 46
SINGULAIR 221 149 24 77
PANTOPRAZOLE SODIUM 219 191 25 45
LISINOPRIL-HYDROCHLOROTHIAZIDE 196 186 26 26
DONEPEZIL HCL 188 178 27 31
ENALAPRIL MALEATE 188 176 27 38
GLYBURIDE-METFORMIN HCL 187 187 R 29 95
ATENOLOL-CHLORTHALIDONE 182 182 30 191
CIALIS 180 167 31 176
ALPRAZOLAM 172 160 32 37
AZITHROMYCIN 170 160 33 34
TRAMADOL HCL 167 153 34 17
NAPROXEN 165 147 35 68
MEGESTROL ACETATE 146 141 R 36 152
CLOTRIMAZOLE-BETAMETHASONE 144 115 37 94
FUROSEMIDE 142 127 38 9
TEMAZEPAM 136 127 39 56
LANTUS 135 134 40 57
ATORVASTATIN CALCIUM 133 117 41 15
LIDODERM 131 91 42 78
CELEBREX 122 92 43 100
CARVEDILOL 121 120 44 23
DICLOFENAC SODIUM 115 99 45 74
ESCITALOPRAM OXALATE 114 112 46 71
DOXAZOSIN MESYLATE 113 113 47 63
TAMSULOSIN HCL 112 104 48 33
SEROQUEL 109 93 49 172
LACTULOSE 108 106 50 126
BENICAR 106 77 51 131
INSULIN SYRINGE 105 103 52 91
ACTOS 102 102 53 133
CYMBALTA 102 75 53 73
MELOXICAM 102 101 53 29
LEXAPRO 100 87 56 184
EXELON 100 89 56 123
VESICARE 97 97 58 205
ABILIFY 97 47 58 162
WARFARIN SODIUM 96 96 60 18
PROAIR HFA 96 72 60 54
GLIPIZIDE 95 92 62 40
HYDROCHLOROTHIAZIDE 92 88 63 10
MECLIZINE HCL 91 90 64 96
ALLOPURINOL 91 90 64 35
BENICAR HCT 88 78 66 155
MUPIROCIN 84 79 67 132
KETOCONAZOLE 83 63 68 118
TRICOR 82 60 69 130
CIPROFLOXACIN HCL 82 74 69 52
LYRICA 79 54 71 105
AMLODIPINE BESYLATE-BENAZEPRIL 79 79 71 65
POTASSIUM CHLORIDE 79 75 71 24
FLUTICASONE PROPIONATE 77 67 74 32
SURE COMFORT 76 68 75 159
CILOSTAZOL 74 68 76 163
RESTASIS 73 61 77 264
VENTOLIN HFA 73 69 77 80
GLYBURIDE 69 64 R 79 55
FAMOTIDINE 68 58 80 70
VITAMIN D2 67 63 81 124
DETROL LA 65 59 82 262
SYMBICORT 64 54 83 160
LOSARTAN POTASSIUM 62 62 84 14
IBANDRONATE SODIUM 58 58 85 253
ALENDRONATE SODIUM 58 58 85 22
ACTONEL 53 52 87 197
MONTELUKAST SODIUM 53 38 87 151
CLOBETASOL PROPIONATE 52 51 89 187
DEXILANT 52 38 89 222
SERTRALINE HCL 50 42 91 28
CYCLOBENZAPRINE HCL 50 49 R 91 72
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.